STOCK TITAN

Evolent Health Inc - EVH STOCK NEWS

Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.

Overview of Evolent Health, Inc.

Evolent Health, Inc. (NYSE: EVH) is a prominent player in the healthcare technology and services sector, dedicated to transforming the delivery of healthcare through its innovative solutions. Headquartered in Arlington, Virginia, Evolent collaborates with health systems, physician organizations, and health plans to facilitate the transition from traditional fee-for-service models to value-based care. By integrating advanced technology, data analytics, and specialized expertise, Evolent supports healthcare providers in achieving better patient outcomes while controlling costs.

Business Model and Core Services

Evolent operates at the intersection of healthcare delivery and payment systems, offering a comprehensive suite of solutions designed to optimize care management and streamline administrative processes. The company’s primary offerings include:

  • Specialty Care Management: Focused on managing high-cost, complex conditions such as oncology, cardiology, and musculoskeletal disorders, Evolent provides condition-specific care management services that improve clinical outcomes and reduce costs.
  • Total Cost of Care Management: Evolent employs a holistic approach to managing healthcare expenses, leveraging data-driven insights to identify cost-saving opportunities and enhance care coordination.
  • Administrative Services: Through its integrated platform, Evolent offers health plan administration and value-based business infrastructure, enabling healthcare organizations to focus on patient care while optimizing operational efficiency.

Technology and Innovation

A key differentiator for Evolent is its commitment to leveraging advanced technology to enhance healthcare delivery. The company’s acquisition of Machinify Auth exemplifies its focus on integrating artificial intelligence (AI) into clinical workflows. This AI-powered platform streamlines complex medical decision-making processes by automating data collection and analysis, reducing administrative burdens for clinicians, and enabling more efficient and accurate case reviews. By embedding such innovative solutions into its offerings, Evolent empowers healthcare providers to deliver higher-value care.

Market Position and Competitive Landscape

Evolent operates in the rapidly evolving healthcare technology and services industry, competing with firms like Optum and Change Healthcare. Its focus on value-based care and specialty condition management positions it uniquely within the market. By addressing the needs of both payers and providers, Evolent bridges the gap between clinical quality and financial sustainability. Its partnerships with leading health plans and healthcare systems further solidify its role as a trusted partner in the industry.

Value Proposition

Evolent’s value proposition lies in its ability to deliver measurable improvements in patient outcomes while reducing costs for healthcare organizations. By combining advanced technology, data-driven insights, and clinical expertise, the company enables its clients to navigate the complexities of value-based care with confidence. This dual focus on quality and affordability makes Evolent an indispensable ally for healthcare providers aiming to thrive in an increasingly value-driven landscape.

Conclusion

In summary, Evolent Health, Inc. stands out as a leader in the healthcare technology and services sector, offering innovative solutions that address the challenges of transitioning to value-based care. Its comprehensive suite of services, technological advancements, and strategic partnerships underscore its commitment to transforming healthcare delivery and achieving better outcomes for patients, providers, and payers alike.

Rhea-AI Summary
Evolent Health's ACO saved Medicare over $55 million in 2022, ranking in the top 2% of ACOs. The ACO improved quality and reduced costs by 5.6%. Evolent's Performance Suite partnership with Humana in North Florida to launch on September 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.76%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
conferences
-
Rhea-AI Summary
Evolent Health, Inc. announces Q2 2023 financial results with revenue of $469.1 million, an increase of 46.6% compared to the same period last year. Net loss margin was (8.8%) and Adjusted EBITDA margin was 10.1%. Total Lives on Platform increased to 78.6 million. The company signed new operating partnerships and expansions, showing strong business momentum. CEO Seth Blackley raises Adjusted EBITDA range for 2023 and expresses confidence in the company's medium-term target of $300 million in Adjusted EBITDA run-rate exiting 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
Rhea-AI Summary
Evolent Health Inc. (NYSE: EVH) appoints Toyin Ajayi, M.D., as the ninth independent board member, bringing expertise as a CEO, physician, and advocate for improving health care quality and cost for underserved populations. Dr. Ajayi's background in leading health care companies focused on Medicaid and dually eligible populations aligns with Evolent's mission of delivering value-based specialty care solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.5%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.73%
Tags
-
Rhea-AI Summary
Evolent Health, a health care company, is rebranding as Evolent and integrating its portfolio of solutions and businesses under that name. The company aims to improve health outcomes by working across specialties, providers, and settings. The rebranding includes a new tagline and corporate logo.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.3%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
-
Rhea-AI Summary

Evolent Health has nominated Richard Jelinek for election to its Board of Directors at the upcoming annual meeting scheduled for June 8, 2023. Jelinek, who is a managing partner at Czech One Capital Partners, has extensive experience in the health care sector, including executive roles at Aetna and CVS Health. His appointment coincides with the departure of current board member David Farner and former Chairman Frank Williams, both set to leave the board in June 2023. Evolent's leadership believes Jelinek's expertise will enhance the board's perspectives and support the company’s mission in value-based specialty care. The board expressed gratitude for the contributions of Farner and Williams, emphasizing the importance of evolving governance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
management
Rhea-AI Summary
Evolent Health, Inc. will release its Q1 2023 financial results on May 3, 2023, with a conference call to follow. The company will also host an Investor Day on May 23, 2023, featuring presentations on its long-term corporate strategy and financial outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags

FAQ

What is the current stock price of Evolent Health (EVH)?

The current stock price of Evolent Health (EVH) is $9.31 as of March 6, 2025.

What is the market cap of Evolent Health (EVH)?

The market cap of Evolent Health (EVH) is approximately 1.0B.

What does Evolent Health, Inc. do?

Evolent Health, Inc. provides technology-driven solutions to support healthcare providers in transitioning to value-based care, focusing on specialty care management, total cost of care management, and administrative services.

How does Evolent generate revenue?

Evolent generates revenue through long-term contracts and subscription fees for its specialty care management, total cost of care management, and administrative services.

What is value-based care?

Value-based care is a healthcare delivery model that prioritizes patient outcomes and cost efficiency by rewarding providers for delivering high-quality care rather than the volume of services provided.

What industries does Evolent Health serve?

Evolent primarily serves the healthcare industry, including health systems, physician organizations, and health plans, focusing on specialty care and population health management.

What are Evolent’s competitive advantages?

Evolent’s competitive advantages include its integration of advanced AI technology, focus on managing complex conditions, and its comprehensive value-based care solutions tailored to both payers and providers.

What is the significance of Evolent’s acquisition of Machinify Auth?

The acquisition of Machinify Auth enhances Evolent’s capabilities in AI-driven clinical decision support, streamlining administrative processes and improving the quality and efficiency of healthcare delivery.

What are the key challenges Evolent faces in its industry?

Key challenges include competition from other healthcare technology providers, regulatory complexities, and the inherent difficulties in transitioning organizations to value-based care models.

What is Evolent’s role in the healthcare ecosystem?

Evolent acts as a bridge between healthcare providers and payers, offering solutions that improve patient care, reduce costs, and enable the adoption of value-based care models.

How does Evolent’s technology benefit healthcare providers?

Evolent’s technology, including AI-driven platforms, reduces administrative burdens, improves clinical decision-making, and supports providers in delivering cost-effective, high-quality care.

Who are Evolent Health’s key competitors?

Key competitors include Optum, Change Healthcare, and other firms specializing in healthcare technology and value-based care solutions.
Evolent Health Inc

NYSE:EVH

EVH Rankings

EVH Stock Data

1.02B
113.93M
2.07%
113.87%
9.82%
Health Information Services
Services-management Services
Link
United States
ARLINGTON